The Ferric Pyrophosphate Market presents strong growth opportunities driven by rising anemia cases, increasing demand for functional foods, and advancements in renal therapies. However, regulatory ...
Shortages of pyrophosphate (PYP), the radiopharmaceutical most commonly used in the U.S. for noninvasive diagnosis of transthyretin (ATTR) cardiac amyloidosis, should not delay imaging in at-risk ...
Calcium pyrophosphate disease remains—50 years after its initial description—a challenging disease to diagnose and manage. Newly-reached consensus among European experts suggests standard nomenclature ...
Calcium pyrophosphate deposition disease (CPPD) is a form of arthritis characterised by the accumulation of calcium pyrophosphate crystals within the joint cartilage and surrounding tissues. This ...
Researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of European and African descent. This crystalline arthritis is caused ...
Please provide your email address to receive an email when new articles are posted on . Utilization of pyrophosphate imaging to identify patients with cardiac amyloidosis has increased, although ...
In a first-of-its-kind genome-wide association study (GWAS) researchers have discovered two genes, RNF144B and ENPP1, that cause calcium pyrophosphate deposition (CPPD) disease in Americans of ...
This article was originally published in HCPLive® and has been lightly edited. The risk of fractures is almost doubled for individuals with acute calcium pyrophosphate crystal arthritis compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results